Safety and tolerability of bosutinib in patients with amyotrophic lateral sclerosis (iDReAM study): A multicentre, open-label, dose-escalation phase 1 trial
2022 · EClinicalMedicine · 49 citations
https://doi.org/10.1016/j.eclinm.2022.101707
N
Naohiro Egawa
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
57
Papers
2.5K
Citations
18
h-index
25
i10-index
Naohiro Egawa is an academic researcher from National Institute for Physiological Sciences. The author has contributed to research in topics: Neurogenesis and neuroplasticity mechanisms & Amyotrophic Lateral Sclerosis Research & Pluripotent Stem Cells Research. The author has an h-index of 18, co-authored 49 publications.
ORCID: 0000-0001-9283-3170Papers by this author
worksTDP-43 regulates cholesterol biosynthesis by inhibiting sterol regulatory element-binding protein 2
2022 · Scientific Reports · 23 citations
https://doi.org/10.1038/s41598-022-12133-4
Mutant α-synuclein causes death of human cortical neurons via ERK1/2 and JNK activation
2024 · Molecular Brain · 13 citations
https://doi.org/10.1186/s13041-024-01086-6
Cellular analysis of SOD1 protein-aggregation propensity and toxicity: a case of ALS with slow progression harboring homozygous SOD1-D92G mutation
2022 · Scientific Reports · 12 citations
https://doi.org/10.1038/s41598-022-16871-3
Predictive Diagnostic Approach to Dementia and Dementia Subtypes Using Wireless and Mobile Electroencephalography: A Pilot Study
2022 · Bioelectricity · 5 citations
https://doi.org/10.1089/bioe.2021.0030
Characterization of astrocytic primary cilia in the adult mouse cortex and hippocampus
2025 · Heliyon · 0 citations
https://doi.org/10.1016/j.heliyon.2025.e44010
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat